Belite Bio (BLTE) Prepaid Assets (2021 - 2025)

Belite Bio's quarterly Prepaid Assets came in at $1.2 million in Q4 2025, up 177.78% year-on-year from $414000.0 in Q4 2024, and up 177.78% quarter-over-quarter from $414000.0 in Q4 2024.

Belite Bio has reported Prepaid Assets for 5 years, with the latest figure at $1.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets rose 177.78% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2025 stood at $1.2 million (up 177.78% YoY), and the FY2025 full-year result was $1.2 million, up 177.78% from the prior year.
  • Prepaid Assets for Q4 2025 stood at $1.2 million, up from $414000.0 in the prior quarter.
  • The five-year high for Prepaid Assets was $1.2 million in Q4 2025, with the low at $50000.0 in Q4 2021.
  • Average Prepaid Assets over 5 years is $515600.0, with a median of $414000.0 recorded in 2024.
  • Year-over-year, Prepaid Assets surged 304.0% in 2022 and slumped 45.67% in 2024.
  • Tracing BLTE's Prepaid Assets over 5 years: stood at $50000.0 in 2021, then surged by 304.0% to $202000.0 in 2022, then jumped by 277.23% to $762000.0 in 2023, then slumped by 45.67% to $414000.0 in 2024, then soared by 177.78% to $1.2 million in 2025.
  • The last three Prepaid Assets figures came in at $1.2 million (Q4 2025), $414000.0 (Q4 2024), and $762000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Belite Bio 4.92 Bn 4.45 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.15 Mn
Sep 30, 2025 -481,000.00
Dec 31, 2024 414,000.00
Sep 30, 2024 -711,000.00
Dec 31, 2023 947,000.00
Dec 31, 2022 716,000.00
Dec 31, 2021 50,000.00